Janux Therapeutics与百时美施贵宝达成合作:后者将主导新药临床试验申请及后续全球开发商业化

美股速递
Jan 22

根据最新合作协议框架,Janux Therapeutics, Inc. 与百时美施贵宝已明确分工:百时美施贵宝将全面负责新药临床试验申请的提交工作,并主导后续所有开发阶段及全球商业化布局。这一合作模式凸显了双方在创新药物领域的战略协同,预计将加速相关疗法的研发进程与市场渗透。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10